Throughout the podcast, the hosts explore how the Geneva Learning Foundation (TGLF) has developed a five-step process to improve HPV vaccination implementation through their “Teach to Reach” program. This process involves:
Gathering experiences from health workers worldwide
Analyzing these experiences for patterns and innovative solutions
Conducting deep dives into specific case studies
Bringing national EPI planners into the conversation
Synthesizing and sharing knowledge back with frontline workers
The hosts emphasize that this approach represents a shift from traditional top-down strategies to one that values the collective intelligence of over 16,000 global health workers who implement these programs.
Surprising findings
The AI hosts discuss several findings from peer learning that may seem counterintuitive, including:
Tribal communities often show less vaccine hesitancy than urban populations, potentially due to stronger community ties and trust in traditional leaders
Teachers sometimes have more influence than health workers when it comes to vaccination recommendations
Simple, clear communication is often more effective than complex strategies
Religious institutions can become powerful allies when approached respectfully
Male community leaders can be crucial advocates for what’s typically framed as a women’s health issue
Effective implementation strategies
The hosts highlight various successful implementation approaches mentioned in Sadki’s article:
Cancer survivors serving as powerful advocates
WhatsApp groups connecting community health workers for information sharing
Engaging schoolchildren as messengers to initiate family conversations
Integrating vaccination efforts with existing women’s groups
Community theater and traditional storytelling methods
Less formal settings often producing better results than clinical environments
System-level insights
The podcast discussion reveals that successful vaccination programs don’t necessarily require abundant resources. Instead, key factors include:
Strong leadership and clear vision
Commitment to continuous learning
Community mobilization and trust-building
Leveraging informal networks
Prioritizing social factors over technical ones
Local adaptation rather than standardization
The AI hosts conclude by reflecting on how these principles challenge global health epidemiologists to reconsider their roles—moving beyond data analysis to becoming facilitators who empower communities to develop their own solutions.
This article is based on my presentation about HPV vaccination at the 2nd National Conference on Adult Immunization and Allied Medicine of the Indian Society for Adult Immunization (ISAI), Science City, Kolkata, on 15 February 2025.
The HPV vaccination implementation challenge
The global landscape of HPV vaccination and cervical cancer prevention reveals a mix of progress and persistent challenges. While 144 countries have introduced HPV vaccines nationally and vaccination has shown remarkable efficacy in reducing cervical cancer incidence, significant disparities persist, particularly in low- and middle-income countries.
Evidence suggests that challenges in implementing and sustaining HPV vaccination programs in developing countries are significantly influenced by gaps between planning at national level and execution at local levels. Multiple studies confirm this disconnect as a primary barrier to effective HPV vaccination programmes.
Traditional approaches to knowledge development in global health often rely on expert committee models characterized by hierarchical knowledge flows, formal meeting processes, and bounded timelines. While these approaches offer strengths like high academic rigor and systematic review, they frequently miss frontline insights, develop slowly, and produce static outputs that may be difficult to translate effectively into action.
How the peer learning network alternative can support HPV vaccination
At The Geneva Learning Foundation (TGLF), we have developed a complementary model—one that values the collective intelligence of frontline health workers and creates structured opportunities for their insights to inform policy and practice. This peer learning network model features:
Large, diverse networks with multi-directional knowledge flow
Open participation and flexible engagement
Direct field experience and implementation insights
Iterative development through experience sharing
Continuous refinement and living knowledge
This approach captures practical knowledge, enables rapid learning cycles, preserves context, and brings together multiple perspectives in a dynamic process that continuously updates as new information emerges.
HPV vaccination: the peer learning cycle in action
To address HPV vaccination challenges, we implemented a structured five-stage cycle that connected frontline experiences with policy decisions:
Experience collection at scale: In June 2023, we engaged over 16,000 health professionals to share their HPV vaccination experiences through our Teach to Reach programme. This stage focused specifically on capturing frontline implementation challenges and solutions across diverse contexts.
Synthesis and analysis: TGLF’s Insights Unit identified key themes, success patterns, and common challenges while highlighting local innovations and practical solutions that emerged from the field.
Knowledge deepening: In October 2023, we conducted a second round of experience sharing that built upon earlier discussions at Teach to Reach. This stage featured more in-depth case studies and implementation stories, providing additional contexts and approaches to vaccination challenges.
National-level review: In January 2024, we facilitated a consultation with national EPI (Expanded Programme on Immunization) planners from 31 countries. This created direct connections between field experience and national strategy, validating and enriching the collected insights.
Knowledge mobilization: Finally, we synthesized the insights into practical guidance, ready for sharing back to frontline workers, and established a foundation for continued learning cycles.
This process uniquely values the practical wisdom that emerges from implementation experience. Rather than assuming solutions flow from the top down, we recognize that those doing the work often develop the most effective approaches to complex challenges.
Teach to Reach: Building a learning community for HPV vaccination
Our Teach to Reach programme serves as the hub for this peer learning approach. Since its inception, the community has grown steadily since January 2021 to reach over 24,000 members by December 2024. The participants reflect remarkable diversity.
This diversity of contexts and experiences creates a rich environment for learning. The programme demonstrates significant impact on participants’ professional capabilities—compared to global baselines, Teach to Reach participants show:
45% stronger worldview change
41% greater impact on professional practice
49% higher professional influence
7 insights about HPV vaccination from peer learning at Teach to Reach
Through this process, we uncovered several important implementation insights:
1. Importance of connecting field experience to policy
Each stage deepened understanding of implementation challenges
We observed progression from tactical to strategic considerations
Growing recognition of systemic factors emerged
Evolution from individual to institutional solutions became apparent
Value of structured knowledge sharing across levels was demonstrated
2. Implementation learning
Success requires multi-stakeholder engagement
Sustained communication proves more effective than one-time campaigns
School systems provide critical implementation platforms
Community leadership is essential for acceptance
Integration with other services increases efficiency
Local adaptation is key to successful implementation
3. Unexpected implementation findings
Tribal communities often showed less vaccine hesitancy than urban areas
Teachers emerged as more influential than health workers in some contexts
Personal stories proved more persuasive than statistical evidence
Integration with COVID-19 vaccination improved HPV acceptance
Social media played both positive and negative roles
School-based programs sometimes reached out-of-school children
4. Counter-intuitive success factors
Less formal settings often produced better results
Simple communication strategies outperformed complex ones
Male community leaders became strong vaccination advocates
Religious institutions provided unexpected support
Health worker vaccination of own children became powerful tool
Community dialogue proved more effective than expert presentations
5. Unexpected challenges
Urban areas sometimes showed more resistance than rural areas
Education level did not correlate with vaccine acceptance
Health workers themselves sometimes showed hesitancy
Traditional media was less influential than anticipated
Formal authority figures were not always the most effective advocates
Technical knowledge proved less important than communication skills
6. Examples of novel solutions
Using cancer survivors as advocates
WhatsApp groups for community health workers
School children as messengers to families
Integration with existing women’s groups
Leveraging religious texts and teachings
Community theater and storytelling approaches
System-level surprises
Success was often independent of resource levels
Informal networks proved more important than formal ones
Bottom-up strategies were more effective than top-down approaches
Social factors were more influential than technical ones
Local adaptation was more important than standardization
Peer influence was more powerful than expert authority
In some cases, these findings challenge many conventional assumptions about HPV vaccination programmes. In all cases, they highlight the importance of local knowledge, social factors, and adaptation over standardized approaches based solely on technical expertise.
The power of health worker collective intelligence
Our approach demonstrates the value of health worker collective intelligence in improving performance:
High-quality data and situational intelligence from our network of 60,000+ health workers provides rapid insights
Field observations on changing disease patterns and resistance can be quickly collected
Climate change impacts can be tracked through frontline reports
The TGLF Insights Unit packages this intelligence into knowledge to inform practice and policy
This represents a fundamental shift from assuming expert committees have all the answers to recognizing the distributed expertise that exists throughout health systems.
Continuous learning: The key to improvement
In fact, previous TGLF research has demonstrated that continuous learning is often the “Achilles’ heel” in immunization programs. Common issues include:
Relative lack of learning opportunities
Limited ability to experiment and take risks
Low tolerance for failure
Focus on task completion at the expense of building capacity for future performance
Lack of encouragement for learning tied to tangible organizational incentives
In 2020 and 2022, we conducted large-scale measurements of learning culture of more than 10,000 immunization professionals in low- and middle-income countries. The data showed that ‘learning culture’ (a measure of the capacity for change) correlated more strongly with perceived programme performance than individual motivation did. This challenges the common assumption that poor motivation is the root cause of poor performance.
These findings help zero in on six ways to strengthen continuous learning to drive HPV vaccination:
Motivate health workers to believe strongly in the importance of what they do
Give them practice dealing with difficult situations they might face
Build mental resilience for facing obstacles
Prompt them to enlist coworkers for support
Help them engage their bosses to provide guidance, support, and resources
Help them identify and overcome workplace obstacles
Impact and benefits of peer learning
This approach delivers multiple benefits:
Frontline workers gain broader perspective
National planners access grounded insights
Practical solutions spread more quickly
Policy decisions are informed by field experience
Continuous improvement cycle gets established
Key success factors include:
Scale that enables diverse input collection
Structure that supports quality knowledge creation
Regular rhythm that maintains engagement
Multiple levels of review that ensure relevance
Clear pathways from insight to action
How can we interpret these findings?
This model generates implementation-focused evidence that complements rather than competes with traditional epidemiological data.
The findings emerge from a structured methodology that includes initial experience collection at scale, synthesis and analysis, knowledge deepening through case studies, national-level review by EPI planners from 31 countries, and systematic knowledge mobilization. This approach provides rigor and scale that elevate these observations beyond mere anecdotes.
For epidemiologists who become uncomfortable when evidence is not purely quantitative, it is important to understand that structured peer learning fills a critical gap in implementation science by capturing what quantitative studies often miss: the contextual factors and practical adaptations that determine programme success or failure in real-world settings.
When implementers report across different contexts that tribal communities show less vaccine hesitancy than urban areas, or that teachers emerge as more influential than health workers in specific settings, these patterns represent valuable implementation intelligence.
Such insights also help explain why interventions that appear effective in controlled studies often fail to deliver similar results when implemented at scale.
In fact, these findings address precisely what quantitative studies struggle to capture: why education level does not reliably predict vaccine acceptance; why some resource-constrained settings outperform better-resourced ones; how informal networks frequently prove more effective than formal structures; and which communication approaches actually drive behavior change in specific populations.
For programme planners, this knowledge bridges the gap between general guidance (“engage community leaders”) and actionable specifics (“male community leaders became particularly effective advocates when engaged through these specific approaches”).
Accelerating HPV vaccination progress
To make significant progress on HPV vaccination as part of the Immunization Agenda 2030’s Strategic Priority 4 (life-course and integration), we encourage global health stakeholders to:
Rethink how we learn
Question how we engage with families and communities
Focus on trust
By combining expert knowledge with the practical wisdom of thousands of implementers, we can develop more effective strategies for HPV vaccination that bridge the gap between planning and execution.
This peer learning network approach does not replace expertise—it enhances and grounds it in the realities of implementation.
It recognizes that the frontline health worker in a remote village may hold insights just as valuable as those of a technical expert in a capital city.
By creating structures that enable these insights to emerge and connect, we can accelerate progress on HPV vaccination and other public health challenges.
Acknowledgements
I wish to thank ISAI’s Dr Saurabh Kole and his colleagues for their kind invitation. I also wish to recognize and appreciate Charlotte Mbuh and Ian Jones for their invaluable contributions to the Foundation’s work on HPV vaccination, and Dr Satabdi Mitra for her tireless leadership and boundless commitment. Last but not least, I wish to thank the thousands of health workers who contributed their experiences before, during, and after successive Teach to Reach peer learning events. What little I know comes from their collective intelligence, action, and wisdom.
References
Dorji, T. et al. (2021) ‘Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis’, EClinicalMedicine, 34, p. 100836. Available at: https://doi.org/10.1016/j.eclinm.2021.100836.
Faye, W. et al. (2023) IA2030 Case study 18. Wasnam Faye. Vaccine angels – Give us the opportunity and we can perform miracles. The Geneva Learning Foundation. Immunization Agenda 2030 Case study 18. Available at: https://doi.org/10.5281/ZENODO.7785244.
Gonçalves, I.M.B. et al. (2020) ‘HPV Vaccination in Young Girls from Developing Countries: What Are the Barriers for Its Implementation? A Systematic Review’, Health, 12(06), pp. 671–693. Available at: https://doi.org/10.4236/health.2020.126050.
Jones, I. et al. (2024) Making connections at Teach to Reach 8 (IA2030 Listening and Learning Report 6). Available at: https://doi.org/10.5281/ZENODO.8398550.
Jones, I. et al. (2022) IA2030 Case Study 7. Motivation, learning culture and programme performance. The Geneva Learning Foundation. Available at: https://doi.org/10.5281/ZENODO.7004304.
Kutz, J.-M. et al. (2023) ‘Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review’, BMC Public Health, 23(1), p. 974. Available at: https://doi.org/10.1186/s12889-023-15842-1.
Moore, K. et al. (2022) Overcoming barriers to vaccine acceptance in the community: Key learning from the experiences of 734 frontline health workers. The Geneva Learning Foundation. Available at: https://doi.org/10.5281/ZENODO.6965355.
Umbelino-Walker, I. et al. (2024) ‘Towards a sustainable model for a digital learning network in support of the Immunization Agenda 2030 –a mixed methods study with a transdisciplinary component’, PLOS Global Public Health. Edited by M. Pentecost, 4(12), p. e0003855. Available at: https://doi.org/10.1371/journal.pgph.0003855.
Watkins, K.E. et al. (2022) ‘Accelerating problem-solving capacities of sub-national public health professionals: an evaluation of a digital immunization training intervention’, BMC Health Services Research, 22(1), p. 736. Available at: https://doi.org/10.1186/s12913-022-08138-4.
Wigle, J., Coast, E. and Watson-Jones, D. (2013) ‘Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects’, Vaccine, 31(37), pp. 3811–3817. Available at: https://doi.org/10.1016/j.vaccine.2013.06.016.